CLINICAL_TRIALS
trial_result
· 2013-04-15
Clinical Trial Update: A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA) [Phase 2]
Summary
Chelsea Therapeutics reports completion of a Phase 2 clinical trial evaluating CH-4051 in patients with rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chelsea Therapeutics | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED